Seroatlas · Human Serome Atlas

C6orf52

Putative uncharacterized protein C6orf52

Also known as: CF052_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q5T4I8
Gene
C6orf52
Ensembl
ENSG00000137434
Chromosome
6
Canonical length
152 aa
Protein class
Predicted intracellular proteins
Subcellular location
Nuclear speckles,Intermediate filaments

OverviewNCBI Gene

No narrative summary is available for C6orf52 in this catalog release; identity and structured annotations are shown without generated factual claims.

Canonical amino-acid sequenceUniProt

152 residues, UniProt reviewed canonical sequence.

>Q5T4I8|C6orf52
     1  MAQPESSADF GIAQQNNYYC YWQSLPSAIR VKQEFQPSQS YRYGNWYARQ HGSYLLSGYS
    61  YGCAVDGNGK DCFSAHETPE HTAGTLVMPK ETTPLAENQD EDPLEDPHLH LNIEESNQEF
   121  MVKSEELYDS LMNCHWQPLD TVHSEIPDET PK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against C6orf52 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Unknown
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.65
Highest tissue expression
13 nTPM

Expression across tissuesHPA

Tissue

  • testis: 13 nTPM
  • amygdala: 4.3 nTPM
  • hypothalamus: 4.2 nTPM
  • kidney: 4.2 nTPM
  • midbrain: 3.9 nTPM
  • hippocampal formation: 3.7 nTPM

Single-cell type

  • oocytes: 1,243 nCPM
  • late primary spermatocytes: 78 nCPM
  • early spermatids: 36 nCPM
  • endometrial ciliated cells: 33 nCPM
  • fallopian tube ciliated cells: 30 nCPM
  • late spermatids: 25 nCPM

Immune cell

  • T-reg: 4.2 nTPM
  • eosinophil: 2.7 nTPM
  • memory CD4 T-cell: 0.8 nTPM
  • gdT-cell: 0.7 nTPM
  • memory CD8 T-cell: 0.6 nTPM
  • myeloid DC: 0.6 nTPM

Brain region

  • choroid plexus: 3.8 nTPM
  • midbrain: 3.3 nTPM
  • medulla oblongata: 2.9 nTPM
  • hypothalamus: 2.6 nTPM
  • white matter: 2.6 nTPM
  • pons: 2.4 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.66
gnomAD pLI
0
gnomAD missense Z
0.68
DepMap mean gene effect
0.04
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

Protein domainsUniProt · Pfam · InterPro

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads C6orf52 as an antibody target. Whether an autoantibody or antibody against C6orf52 could matter depends on whether native C6orf52 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

C6orf52 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label C6orf52 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/C6orf52. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...